Moving towards optimized treatment for children and adolescents with juvenile idiopathic arthritis in sustained remission randomized to continue stable treatment, methotrexate withdrawal or tumor necrosis factor inhibitor withdrawal: study protocol for the Norwegian multi-center MOVE-JIA trial
- DOI
- 10.1186/s13063-026-09539-0
- Published
- 2026-02-17
- Container
- Trials
- Publisher
- Springer Science and Business Media LLC
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1186/s13063-026-09539-0,
title = {Moving towards optimized treatment for children and adolescents with juvenile idiopathic arthritis in sustained remission randomized to continue stable treatment, methotrexate withdrawal or tumor necrosis factor inhibitor withdrawal: study protocol for the Norwegian multi-center MOVE-JIA trial},
author = {Siri Opsahl Hetlevik and Vibke Lilleby and Maiju Pesonen and Ellen Nordal and Marite Rygg and Cathrine Austad and Maria Karolina Jonsson and Maria Bilstad and Hege Kilander Høiberg and Nina Krafft Sande and Berit Flatø and Siri Lillegraven and Espen A. Haavardsholm and Athimalaipet V. Ramanan and Øyvind Molberg and Pernille Bøyesen and Anna-Birgitte Aga},
year = {2026},
journal = {Trials},
doi = {10.1186/s13063-026-09539-0},
url = {https://doi.org/10.1186/s13063-026-09539-0}
}RIS
TY - JOUR TI - Moving towards optimized treatment for children and adolescents with juvenile idiopathic arthritis in sustained remission randomized to continue stable treatment, methotrexate withdrawal or tumor necrosis factor inhibitor withdrawal: study protocol for the Norwegian multi-center MOVE-JIA trial AU - Siri Opsahl Hetlevik AU - Vibke Lilleby AU - Maiju Pesonen AU - Ellen Nordal AU - Marite Rygg AU - Cathrine Austad AU - Maria Karolina Jonsson AU - Maria Bilstad AU - Hege Kilander Høiberg AU - Nina Krafft Sande AU - Berit Flatø AU - Siri Lillegraven AU - Espen A. Haavardsholm AU - Athimalaipet V. Ramanan AU - Øyvind Molberg AU - Pernille Bøyesen AU - Anna-Birgitte Aga PY - 2026 JO - Trials DO - 10.1186/s13063-026-09539-0 UR - https://doi.org/10.1186/s13063-026-09539-0 ER -
APA
Hetlevik, S. O., Lilleby, V., Pesonen, M., Nordal, E., Rygg, M., Austad, C., Jonsson, M. K., Bilstad, M., Høiberg, H. K., Sande, N. K., Flatø, B., Lillegraven, S., Haavardsholm, E. A., Ramanan, A. V., Molberg, Ø., Bøyesen, P., & Aga, A. (2026). Moving towards optimized treatment for children and adolescents with juvenile idiopathic arthritis in sustained remission randomized to continue stable treatment, methotrexate withdrawal or tumor necrosis factor inhibitor withdrawal: study protocol for the Norwegian multi-center MOVE-JIA trial. Trials. https://doi.org/10.1186/s13063-026-09539-0
Source records
- crossref · retrieved 2026-09-26T01:28:09.511Z